Point72 Asia Singapore Pte. Ltd. Sells 2,035 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Point72 Asia Singapore Pte. Ltd. lessened its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 68.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 935 shares of the medical instruments supplier’s stock after selling 2,035 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Mettler-Toledo International were worth $1,402,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. PineStone Asset Management Inc. lifted its holdings in shares of Mettler-Toledo International by 127.4% in the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares in the last quarter. Loomis Sayles & Co. L P lifted its holdings in shares of Mettler-Toledo International by 1.8% in the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock valued at $314,790,000 after purchasing an additional 3,644 shares in the last quarter. TD Asset Management Inc lifted its holdings in shares of Mettler-Toledo International by 1.9% in the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock valued at $219,767,000 after purchasing an additional 2,866 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after purchasing an additional 35,048 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in shares of Mettler-Toledo International by 149,870.0% in the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after purchasing an additional 89,922 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on MTD. Robert W. Baird decreased their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Evercore ISI increased their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $1,338.75.

Insider Activity

In other news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,251.20 on Monday. The business has a fifty day simple moving average of $1,345.17 and a two-hundred day simple moving average of $1,392.37. Mettler-Toledo International Inc. has a 1 year low of $1,068.33 and a 1 year high of $1,546.93. The company has a market capitalization of $26.40 billion, a P/E ratio of 33.73, a P/E/G ratio of 4.13 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, analysts anticipate that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.